Literature DB >> 20421745

Testing but not treating: missed opportunities and lost lives in the South African antiretroviral therapy programme.

Joseph N Jarvis, Graeme Meintjes, Robin Wood, Thomas S Harrison.   

Abstract

Entities:  

Mesh：

Year:  2010        PMID： 20421745      PMCID： PMC2872163          DOI： 10.1097/QAD.0b013e3283383aeb

Source DB:  PubMed          Journal:  AIDS        ISSN： 0269-9370            Impact factor:   4.177


× No keyword cloud information.
  11 in total

1.  The changing epidemiology of cryptococcosis: an update from population-based active surveillance in 2 large metropolitan areas, 1992-2000.

Authors:  Sara A Mirza; Maureen Phelan; David Rimland; Edward Graviss; Richard Hamill; Mary E Brandt; Tracie Gardner; Matthew Sattah; Gabriel Ponce de Leon; Wendy Baughman; Rana A Hajjeh
Journal:  Clin Infect Dis       Date:  2003-02-27       Impact factor: 9.079

2.  Efficacy of antiretroviral therapy adherence interventions: a research synthesis of trials, 1996 to 2004.

Authors:  K Rivet Amico; Jennifer J Harman; Blair T Johnson
Journal:  J Acquir Immune Defic Syndr       Date:  2006-03       Impact factor: 3.731

3.  Universal voluntary HIV testing with immediate antiretroviral therapy as a strategy for elimination of HIV transmission: a mathematical model.

Authors:  Reuben M Granich; Charles F Gilks; Christopher Dye; Kevin M De Cock; Brian G Williams
Journal:  Lancet       Date:  2008-11-27       Impact factor: 79.321

Review 4.  Adherence to antiretroviral therapy in sub-Saharan Africa and North America: a meta-analysis.

Authors:  Edward J Mills; Jean B Nachega; Iain Buchan; James Orbinski; Amir Attaran; Sonal Singh; Beth Rachlis; Ping Wu; Curtis Cooper; Lehana Thabane; Kumanan Wilson; Gordon H Guyatt; David R Bangsberg
Journal:  JAMA       Date:  2006-08-09       Impact factor: 56.272

5.  Determinants of mortality and nondeath losses from an antiretroviral treatment service in South Africa: implications for program evaluation.

Authors:  Stephen D Lawn; Landon Myer; Guy Harling; Catherine Orrell; Linda-Gail Bekker; Robin Wood
Journal:  Clin Infect Dis       Date:  2006-08-08       Impact factor: 9.079

6.  Antiretroviral therapy and early mortality in South Africa.

Authors:  Andrew Boulle; Peter Bock; Meg Osler; Karen Cohen; Liezl Channing; Katherine Hilderbrand; Eula Mothibi; Virginia Zweigenthal; Neviline Slingers; Keith Cloete; Fareed Abdullah
Journal:  Bull World Health Organ       Date:  2008-09       Impact factor: 9.408

7.  Effectiveness of antiretroviral treatment in a South African program: a cohort study.

Authors:  Lara R Fairall; Max O Bachmann; Goedele M C Louwagie; Cloete van Vuuren; Perpetual Chikobvu; Dewald Steyn; Gillian H Staniland; Venessa Timmerman; Mpumelelo Msimanga; Chris J Seebregts; Andrew Boulle; Ralph Nhiwatiwa; Eric D Bateman; Merrick F Zwarenstein; Ronald D Chapman
Journal:  Arch Intern Med       Date:  2008-01-14

8.  Fungal burden, early fungicidal activity, and outcome in cryptococcal meningitis in antiretroviral-naive or antiretroviral-experienced patients treated with amphotericin B or fluconazole.

Authors:  Tihana Bicanic; Graeme Meintjes; Robin Wood; Madeleine Hayes; Kevin Rebe; Linda-Gail Bekker; Thomas Harrison
Journal:  Clin Infect Dis       Date:  2007-05-25       Impact factor: 9.079

9.  Mortality and loss-to-follow-up during the pre-treatment period in an antiretroviral therapy programme under normal health service conditions in Uganda.

Authors:  Barbara Amuron; Geoffrey Namara; Josephine Birungi; Christine Nabiryo; Jonathan Levin; Heiner Grosskurth; Alex Coutinho; Shabbar Jaffar
Journal:  BMC Public Health       Date:  2009-08-11       Impact factor: 3.295

10.  High ongoing burden of cryptococcal disease in Africa despite antiretroviral roll out.

Authors:  Joseph N Jarvis; Andrew Boulle; Angela Loyse; Tihana Bicanic; Kevin Rebe; Anthony Williams; Thomas S Harrison; Graeme Meintjes
Journal:  AIDS       Date:  2009-06-01       Impact factor: 4.177
View more
  17 in total

1.  Adjunctive interferon-γ immunotherapy for the treatment of HIV-associated cryptococcal meningitis: a randomized controlled trial.

Authors:  Joseph N Jarvis; Graeme Meintjes; Kevin Rebe; Gertrude Ntombomzi Williams; Tihana Bicanic; Anthony Williams; Charlotte Schutz; Linda-Gail Bekker; Robin Wood; Thomas S Harrison
Journal:  AIDS       Date:  2012-06-01       Impact factor: 4.177

2.  Evaluation of a novel point-of-care cryptococcal antigen test on serum, plasma, and urine from patients with HIV-associated cryptococcal meningitis.

Authors:  Joseph N Jarvis; Ann Percival; Sean Bauman; Joy Pelfrey; Graeme Meintjes; G Ntombomzi Williams; Nicky Longley; Thomas S Harrison; Thomas R Kozel
Journal:  Clin Infect Dis       Date:  2011-09-21       Impact factor: 9.079

Review 3.  Integrating cryptococcal antigen screening and pre-emptive treatment into routine HIV care.

Authors:  Radha Rajasingham; David B Meya; David R Boulware
Journal:  J Acquir Immune Defic Syndr       Date:  2012-04-15       Impact factor: 3.731

4.  Attrition from HIV testing to antiretroviral therapy initiation among patients newly diagnosed with HIV in Haiti.

Authors:  Edva Noel; Morgan Esperance; Megan McLaughlin; Rachel Bertrand; Jessy Devieux; Patrice Severe; Diessy Decome; Adias Marcelin; Janet Nicotera; Chris Delcher; Mark Griswold; Genevive Meredith; Jean William Pape; Serena P Koenig
Journal:  J Acquir Immune Defic Syndr       Date:  2013-03-01       Impact factor: 3.731

5.  One in 4 HIV-Positive South Africans Awaiting ART Initiation Report Condomless Sex With a Serodiscordant Partner.

Authors:  Paul A Shuper; Sandy Pillay; Susan MacDonald; Sarah Christie; Deborah H Cornman; William A Fisher; Jeffrey D Fisher
Journal:  J Acquir Immune Defic Syndr       Date:  2016-07-01       Impact factor: 3.731

Review 6.  Cryptococcal infections: changing epidemiology and implications for therapy.

Authors:  Ricardo M La Hoz; Peter G Pappas
Journal:  Drugs       Date:  2013-05       Impact factor: 9.546

7.  Stigmatising attitudes among people offered home-based HIV testing and counselling in Blantyre, Malawi: construction and analysis of a stigma scale.

Authors:  Peter MacPherson; Emily L Webb; Augustine T Choko; Nicola Desmond; Kondwani Chavula; Sue Napierala Mavedzenge; Simon D Makombe; Treza Chunda; S Bertel Squire; Elizabeth L Corbett
Journal:  PLoS One       Date:  2011-10-26       Impact factor: 3.240

8.  Who starts? Factors associated with starting antiretroviral therapy among eligible patients in two, public HIV clinics in Lilongwe, Malawi.

Authors:  Caryl Feldacker; Derek Johnson; Mina Hosseinipour; Sam Phiri; Hannock Tweya
Journal:  PLoS One       Date:  2012-11-30       Impact factor: 3.240

9.  Long term 5-year survival of persons with cryptococcal meningitis or asymptomatic subclinical antigenemia in Uganda.

Authors:  Elissa K Butler; David R Boulware; Paul R Bohjanen; David B Meya
Journal:  PLoS One       Date:  2012-12-10       Impact factor: 3.240

10.  Cryptococcal Antigenemia in Immunocompromised Human Immunodeficiency Virus Patients in Rural Tanzania: A Preventable Cause of Early Mortality.

Authors:  Emilio Letang; Matthias C Müller; Alex J Ntamatungiro; Namvua Kimera; Diana Faini; Hansjakob Furrer; Manuel Battegay; Marcel Tanner; Christoph Hatz; David R Boulware; Tracy R Glass
Journal:  Open Forum Infect Dis       Date:  2015-04-02       Impact factor: 3.835
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.